• Watson Pharmaceuticals Inc., Parsippany, N.J., said its subsidiary filed an abbreviated new drug application for Nebivolol hydrochloride tablets, a generic version of New York-based Forest Laboratories Inc.'s Bystolic, a beta-adrenergic blocking agent for use in hypertension.